Velocity Clinical Research, Dallas ( Site 3220) — Dallas, Texas

Velocity Clinical Research, Dallas ( Site 3220) is a clinical research site located in Dallas, Texas, United States 75230.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Velocity Clinical Research, Dallas ( Site 3220) has participated in 1 clinical trials.

Therapeutic areas: Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research, Dallas ( Site 3220)?

Velocity Clinical Research, Dallas ( Site 3220) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research, Dallas ( Site 3220) conducted?

Velocity Clinical Research, Dallas ( Site 3220) has 1 clinical trials on record. Their work covers Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD.

Is Velocity Clinical Research, Dallas ( Site 3220) accredited by Crixeo Health?

Velocity Clinical Research, Dallas ( Site 3220) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Velocity Clinical Research, Dallas ( Site 3220)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.